본문 바로가기

기관정보

기관정보 기관정보상세

기관상세정보

학회일반현황
학회일반현황
학회명 국문 한국유전체학회 기관구분 학회
영문 Korea Genome Organization 제재이력 변경이력
전화번호   팩스번호  
홈페이지 www.kogo.or.kr 이메일  
주소 [135703] 서울 강남구 역삼1동 과학기술회관 신관 1011호
대표자 성명 윤성수
소속 서울대학교 직위 교수
임기 2019-01-01 ~ 2019-12-31
실무자 성명 정다혜 연락처(핸드폰)
기업단체구분
연구분야 과학정보
행정인력수 3명 전임연구인력수 0명
설립구분 사단법인 설립일자 1992-04-15
설립목적
											 본 학회는 생물 유전체에 관한 연구 및 그 지식의 보급과 회원 상호간의 친목을 통하여 과학과 기술의 발전에 이바지함을 목적으로 한다.
										
연구윤리제정일 2008-06-27 원문서비스url http://www.genominfo.org
연구윤리내용
										한국유전체학회에서는 연구의 진실성을 위해 학술지 연구 윤리 규정을 제정하며, 윤리 규정 및 표절/중복게재/연구부정행위 등 모든 연구윤리와 연계되는 사항에 대한 심사 및 처리절차는 대한의학학술지편집인협의회에서 제정한 '의학논문 출판 윤리 가이드라인'과 ‘영국 출판위원회의 출판윤리 가이드 라인’(Committee on Publication Ethics(COPE). Guidelines On Good Publication Practice)을 따릅니다.

Copyright: The regulations for acceptance of a manuscript for publication automatically include the consent of the author(s) to transfer the copyright or license to KOGO. Authors should complete a Copyright Agreement Form (CAF) at the time of proofreading. The corresponding author can sign on behalf of any co-authors. The CAF can be obtained from the editorial office. Acceptance of the agreement will ensure full copyright protection and help to disseminate the article to the widest possible readership in print and electronic formats. The authors are responsible for obtaining permission to reproduce copyrighted material from other sources. 
The authors assure that no substantial part of the work has been published or is being considered for publication elsewhere. When any of the results are to appear in another journal, details must be submitted to the Editor-in-Chief, together with a copy of the other paper(s) and the expected date(s) of publication.

Disclaimer: The publisher, editors, and reviewers do not assume any legal responsibility for errors, omissions, or claims, nor do they provide any warranty, expressed or implied, with respect to information published in Genomics & Informatics.

Ethics: Research published in Genomics & Informatics must have been conducted in accordance with institutional, national, and international guidelines concerning the use of animals in research and/or the sampling of endangered species. For the policies on research and publication ethics that are not stated in these instructions, the Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/intro.php?body=publishing_ethics) and the Guidelines on Good Publication (http://publicationethics.org/resources/guidelines) can be applied.
The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

Statement of Informed Consent: Copies of written informed consent and Institutional Review Board (IRB) approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval or study conduct.

Statement of Human and Animal Rights: All human investigations must be conducted according to the principles expressed in the Declaration of Helsinki. All studies involving animals must state that the guidelines for the use and care of laboratory animals of the authors’ institution, or of any national law, were followed.

Authorship: All authors must have participated in the research and/or article preparation. The corresponding author is responsible for ensuring that all individuals included as authors on a manuscript must: 1) agree to be listed; 2) have contributed to the research reported; 3) approve the submitted version of the manuscript. The corresponding author should be prepared to explain the presence and order of these individuals. The statement that all authors have approved the final article should be true and be included in the disclosure. 

Conflict of Interest Statement: The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated. 

Originality and Duplicate Publication: No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the authors will be announced in the journal, their institutes will be informed, and the authors will be penalized.



										
연구윤리파일 연구윤리제정.pdf   다운로드 

LoadingLoading....